1999-2019: changes in drug use and supply in France through the experience of the OFDT's TREND scheme



Summary, OFDT, 9 p.
March 2021

On the occasion of the 20th anniversary of the Emerging Trends and New Drugs (TREND) scheme and the National Detection System of Drugs and Toxic Substances (SINTES), the French Monitoring Centre for Drugs and Drug Addiction (OFDT) looks back on two decades of drug monitoring. An issue of the Théma collection1 published in September 2020 observed the major transformations that have taken place in the field of illicit and misused substances that these two schemes have been able to identify and analyse. After detailing the principles of the TREND-SINTES organisation and its adaptation to changes in practices, uses and contexts, this summary describes the main phenomena observed.

Authors : Agnès Cadet-Taïrou, Michel Gandilhon, Clément Gérome, Magali Martinez, Maitena Milhet, Victor Detrez, Julie-Émilie Adès

Download the PDF file (589 Ko)


Read the complete report in French















Drugs in Europe

2021 EMCDDA European Drug Report

How is the COVID-19 pandemic affecting drug use, supply and services?
Drug use and harms
What are the health costs of drug use in Europe today?
Drug markets
What do the latest data tell us about drug production and trafficking trends?

These and other questions are explored in the 2021 European Drug Report, our annual overview of the drug situation in Europe.

  Statistical Bulletin 2021

The annual Statistical Bulletin contains the most recent available data on the drug situation in Europe provided by the Member States. These datasets underpin the analysis presented in the European Drug Report. All data may be viewed interactively on screen and downloaded in Excel format..

The European Union and the drug phenomenon

miniFAQDrugsEurope.jpgThe European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.